Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Is there an anti-inflammatory effect of estrogen?
- The endothelium
- Endothelial dysfunction
- Leukocyte adhesion to the vascular wall
- Functional and dysfunctional endothelium
- Leukocyte-endothelial cell adhesion
- Estrogen as determinant of cardiovascular risk
- Epidemiological studies of estrogen effects
- The estrogen conundrum
- Coronary atherosclerosis in postmenopause
- Women's health initiative design flaws
- Mouse atherosclerosis study - lesion histology
- Estrogen effects on the cardiovascular system
- Rapid EC activation effects of estrogen
- General model of estrogen effects
- Endothelial nitric oxide synthase (eNOS)
- Effect of 17-beta estradiol on NO release
- Estrogen effect on cGMP and NO
- Membranous and cytosolic estrogen receptors
- Localization of estrogen receptor - flow cytometry
- Estrogen receptors in human endothel
- ER46 and ER66 structure
- RT-PCR and immunoblot of ER46 and ER66
- ERKO mouse cardiovascular studies
- ERKO CV studies
- Membrane translocation of ER46
- Effect of estrogen on signaling sequence
- AKT/protein kinase B: downstream effects
- Estrogen induces AKT phosphorylation
- Src kinases are involved with activation of NO
- Estrogen effect on PI3 kinase activation
- c-Src membrane targeting, ER46 localization
- Model of estrogen induced NO release
- c-Src-dependent E2-induced vasorelaxation
- A complete model of E2 induced NO release
- Endothelial homeostasis
- Future questions
- Kronos early estrogen prevention study
- Comparisons within the KEEPS clinical trial
- KEEPS centers and PIs
- Summary
- Acknowledgements
Topics Covered
- Endothelium
- Endothelial dysfunction
- Estrogen-mediated cardiovascular protection and leukocyte-endothelial cell adhesion
- Estrogen as a determinant of cardiovascular risk
- Effects of estrogen on the cardiovascular system
- Rapid EC activation effects of estrogen
- Effect of estradiol on NO release from human endothelial cells
- Estrogen receptor knockout (ERKO) mouse cardiovascular studies
- Palmitoylation is required for membrane translocation of ER46
- Akt/protein kinase B
- Endothelial homeostasis
- Kronos early estrogen prevention study
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Bender, J. (2007, December 1). Vascular cell signaling by membrane estrogen receptors [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 23, 2024, from https://doi.org/10.69645/ILEI6950.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Jeffrey Bender has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.